<DOC>
	<DOCNO>NCT01660191</DOCNO>
	<brief_summary>The purpose study determine Pitavastatin lower CoQ10 less Atorvastatin Rosuvastatin .</brief_summary>
	<brief_title>A Study Comparing CoQ10 Levels While Taking 3 Different Statins</brief_title>
	<detailed_description>Statins know effectively treat high cholesterol heart disease . However , statin may lower endogenous level Coenzyme10 ( CoQ10 ) . This decrease CoQ10 level may responsible side effect myalgia . Previous study show Pitavastatin may affect CoQ10 level statin , still lower cholesterol . In study , investigator intend compare plasma level CoQ10 patient take 3 different FDA-approved statin , equipotent dos .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>LDLC level 100200mg/dl ; triglyceride &lt; /=200mg/dl screen visit Willing discontinue use lipidaltering dos fo medication supplement duration study LDLC &lt; 100mg/dl &gt; 200mg/dl , Triglycerides &gt; 200mg/dl History diabetes mellitus document fast blood glucose &gt; 125mg/dl HbA1c &gt; 6.4 % History coronary artery disease history chronic renal hepatic disease know sensitivity intolerance statin persistent elevate liver enzymes CPK ( &gt; 3 x upper normal limit ) currently take CoQ10 supplement unable discontinue duration study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>LDL , HDL</keyword>
</DOC>